Alpha Signal Monitor - Daily Market Briefing | March 24, 2026
Daily Market Research Report
March 24, 2026
Alpha Signal Monitor
Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.
Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts
Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM
This report is generated using advanced AI research capabilities with real-time market data access.
Gold ETFs: Institutional Outlook (as of March 24, 2026)
Trading Idea: Buy Rationale (TL;DR): Most major banks see gold higher into late‑2026 on a mix of persistent central‑bank buying, easier US monetary policy and renewed ETF inflows; published targets cluster around ~$4,400–$5,900/oz, skewing risk/reward in favor of long exposure via GLD/IAU/BAR. (goldmansachs.com)
Institutions highlight three reinforcing pillars for gold in 2026: (1) robust official‑sector accumulation (especially EM central banks), (2) an easier Fed/lower real yields with a softer USD that supports non‑yielding assets and ETF demand, and (3) elevated geopolitical and fiscal risks that keep hedging demand firm. (goldmansachs.com)
Key Drivers - Central‑bank purchases remain structurally elevated, underpinning dips. (goldmansachs.com) - US policy easing/lower real rates and a weaker USD are tailwinds for bullion. (citigroup.com) - ETF inflows have returned alongside investor demand for real assets. (ubs.com) - Geopolitical uncertainty and large fiscal deficits sustain safe‑haven bids. (goldmansachs.com) - Constrained mine supply growth and higher cost curves limit downside. (morganstanley.com)
| Institution | Stance | Price View | Key Evidence | Last Update | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Constructive/Bullish | Gold to ~$4,000/oz by mid‑2026 (+~6% from late‑Sep 2025). | Forecast cites strong central‑bank accumulation and Fed easing supporting ETF demand. | 2025-09-30 | (goldmansachs.com) |
| Morgan Stanley | Positive (Wealth Management Research) | Raised 2026 forecast to ~$4,400/oz (from ~$3,313). | Sees continued rally into 2026 on weaker USD, ETF and central‑bank demand; flags risk of demand destruction at high prices. | 2025-10-22 | (morganstanley.com) |
| JP Morgan (Global Commodities Strategy) | Bullish | Average ~$5,055/oz by 4Q26 (quarterly path published). | Notes continued strong investor and official demand driving a higher price regime. | - | (jpmorgan.com) |
| Bank of America (Global Research) | Bullish | Targets ~$5,000/oz in 2026 (with avg near ~$4,400 cited in reports). | Research updates highlighted a 2026 $5,000/oz target; widely reported by mainstream financial media. | 2025-10-13 | (cincodias.elpais.com) |
| Citigroup (Commodities Research) | Constructive near‑term; more balanced at ~$4,200 | Raised 0–3m gold view to ~$4,000; broader 2026 outlook constructive but not a strong buy at ~$4,200. | 4Q’25 commodities outlook lifts short‑term forecast to $4,000; macro team later notes gold less compelling at ~$4,200 while ‘Goldilocks’ backdrop persists. | 2025-12-08 | (citigroup.com) |
| UBS (Chief Investment Office) | Attractive/Long | Raised to ~$6,200/oz for Mar–Sep 2026; ~$5,900 by Dec‑2026. | CIO notes record demand and recommends staying long; updated quarterly targets published 29 Jan 2026. | 2026-01-29 | (ubs.com) |
| HSBC (Precious Metals Strategy) | Positive with range‑bound risks | 2026 average ~$4,586/oz; range $3,950–$5,050/oz. | LBMA 2026 survey entry by James Steel highlights upside risks (geopolitics, USD, deficits) but warns on possible consolidation and demand softness at high prices. | - | (lbma.org.uk) |
| Deutsche Bank (Wealth/Research) | Positive | End‑2026 forecast ~$4,500/oz. | Annual Outlook ‘PERSPECTIVES 2026’ lists forecast table and cites further upside potential for gold. | 2025-12-04 | (wealth.db.com) |
Risk Considerations - Stronger‑than‑expected growth or stickier real yields lifting the USD could cap or reverse gains. (morganstanley.com) - Demand destruction at high prices (jewelry/fabrication) and potential moderation in central‑bank buying. (morganstanley.com) - Positioning risk: crowded longs raise the odds of sharp tactical pullbacks. (goldmansachs.com) - De‑escalation of geopolitical risks could compress the risk premium. (lbma.org.uk)
Consensus skew is bullish into late‑2026; prefer broad, low‑cost physical‑backed exposure (GLD/IAU/BAR) and add on pullbacks while monitoring real yields, the USD, and the pace of official‑sector buying. (goldmansachs.com)
Stock Ratings — Top U.S. Broker Targets and Ratings — Mega‑Cap Tech Semi Check (as of March 24, 2026)
This summary compiles the latest publicly reported target prices/ratings from six major U.S. brokers (Goldman Sachs, Morgan Stanley, JPMorgan, Bank of America, Citigroup, Wells Fargo) for selected large‑cap tech and semiconductor stocks. Primary data are pulled from MarketBeat broker action logs for each ticker, with supplemental items from Investing.com/Yahoo Finance/Capital.com where MarketBeat did not show a target on the most recent entry. See each stock’s narrative for source notes. Citations: AAPL page (MarketBeat). (marketbeat.com) MSFT page (MarketBeat) and MSFT GS/MS items (Capital.com; Investing.com). (marketbeat.com) GOOGL page (MarketBeat) plus JPMorgan’s $395 update (MarketBeat Instant/Investing.com). (marketbeat.com) AMZN page (MarketBeat). (marketbeat.com) NVDA page (MarketBeat). (marketbeat.com)
AAPL - Apple Inc.
Most houses remain Buy/Overweight following early‑2026 updates; MS reiterated Overweight with $315 (Mar 23, 2026) and BofA trimmed to $320 the same day; JPM boosted to $325 on Jan 30, 2026; WFC’s latest is $300 from Oct 31, 2025; GS reiterated Buy on Mar 2, 2026 but the MarketBeat item did not show a target. (marketbeat.com)
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | - | 2026-03-02 | Reiterated rating; target not shown in MarketBeat entry. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Morgan Stanley | Overweight | $315 | 2026-03-23 | Reiterated rating. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| JP Morgan | Overweight | $325 | 2026-01-30 | Raised from $315. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Bank of America | Buy | $320 | 2026-03-23 | Lowered from $325. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Citigroup | Buy | $315 | 2026-01-02 | Lowered from $330. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Wells Fargo | Overweight | $300 | 2025-10-31 | Raised from $290. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
Consensus View - Rating: Buy, Target Price: $315 - Weighted by available broker targets (5 of 6 populated), AAPL screens as a broad Buy/Overweight at ~$315 12‑mo PT.
MSFT - Microsoft Corp.
Across brokers, stance is Buy/Overweight; MS at $650 (Jan 14, 2026), GS at $600 (as of Jan 29, 2026), JPM cut to $550 on Jan 29, 2026; BofA to $520 (Jan 22, 2026); Citi to $635 (Jan 29, 2026); WFC to $615 (Jan 29, 2026). (investing.com)
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $600 | 2026-01-29 | Reissued Buy with $600 12‑mo PT. | https://capital.com/en-int/market-updates/microsoft-stock-forecast-27-02-2026 |
| Morgan Stanley | Overweight | $650 | 2026-01-14 | Reiterated Overweight and $650 PT. | https://www.investing.com/news/analyst-ratings/morgan-stanley-reiterates-overweight-rating-on-microsoft-stock-at-650-93CH-4446158 |
| JP Morgan | Overweight | $550 | 2026-01-29 | Lowered from $575. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Bank of America | Buy | $520 | 2026-01-22 | Lowered from $640. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Citigroup | Buy | $635 | 2026-01-29 | Lowered from $660. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Wells Fargo | Overweight | $615 | 2026-01-29 | Lowered from $630 (Michael Turrin). | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
Consensus View - Rating: Buy, Target Price: $595 - Simple average of six populated targets ≈ $595, implying Buy/OW skew.
GOOGL - Alphabet Inc. (Class A)
GS lifted to $375 (Jan 13, 2026); MS to $330 (Oct 30, 2025); JPM to $395 (Feb 5, 2026); BofA to $370 (Dec 2, 2025); Citi to $390 (Feb 6, 2026); WFC to $354 Equal Weight (Feb 5, 2026). (marketbeat.com)
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $375 | 2026-01-13 | Raised from $330. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Morgan Stanley | Overweight | $330 | 2025-10-30 | Raised from $270. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| JP Morgan | Overweight | $395 | 2026-02-05 | Raised from $385. | https://www.marketbeat.com/instant-alerts/alphabet-nasdaqgoogl-given-new-39500-price-target-at-jpmorgan-chase-co-2026-02-05/ |
| Bank of America | Buy | $370 | 2025-12-02 | Raised from $335. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Citigroup | Buy | $390 | 2026-02-06 | Raised from $350. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Wells Fargo | Equal Weight | $354 | 2026-02-05 | Raised from $350. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
Consensus View - Rating: Buy, Target Price: $369 - Average of six populated targets ≈ $369; ratings skew Buy/OW with one EW.
AMZN - Amazon.com Inc.
GS raised to $300 (Jan 1, 2026); MS reiterated Overweight and cut to $300 (Feb 6, 2026); JPM reiterated Buy on Feb 6, 2026 (no target shown in MarketBeat log); BofA cut to $286 (Jan 26, 2026); Citi trimmed to $250 (Mar 17, 2026); WFC nudged to $304 (Feb 12, 2026). (marketbeat.com)
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $300 | 2026-01-01 | Raised from $290. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Morgan Stanley | Overweight | $300 | 2026-02-06 | Cut from $315. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| JP Morgan | Buy | - | 2026-02-06 | Reiterated rating; target not shown in MarketBeat entry. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Bank of America | Buy | $286 | 2026-01-26 | Lowered from $303. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Citigroup | Buy (Outperform) | $250 | 2026-03-17 | Lowered from $255. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Wells Fargo | Overweight | $304 | 2026-02-12 | Adjusted from $305. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
Consensus View - Rating: Buy, Target Price: $288 - Average of available five targets ≈ $288; ratings Buy/Overweight across the board.
NVDA - NVIDIA Corp.
Post‑Q4 FY26 updates: GS set $250 (Feb 25, 2026); MS logged $260 (Feb 27, 2026); JPM to $265 (Feb 26, 2026); BofA to $300 (Feb 25, 2026); Citi recent press summarized $300 (Feb 26, 2026); WFC reiterated Overweight on Nov 28, 2025 without a target in MarketBeat log. (marketbeat.com)
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $250 | 2026-02-25 | Set target. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Morgan Stanley | Overweight | $260 | 2026-02-27 | Set target. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| JP Morgan | Overweight | $265 | 2026-02-26 | Raised from $250. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Bank of America | Buy | $300 | 2026-02-25 | Raised from $275. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Citigroup | Buy | $300 | 2026-02-26 | Raised per MarketBeat Instant item. | https://www.marketbeat.com/instant-alerts/citigroup-increases-nvidia-nasdaqnvda-price-target-to-30000-2026-02-26/ |
| Wells Fargo | Overweight | - | 2025-11-28 | Reiterated OW; target not shown in MarketBeat entry. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
Consensus View - Rating: Buy, Target Price: $275 - Average of five populated targets ≈ $275; ratings uniformly Buy/OW.
META - Meta Platforms Inc.
Recent earnings commentary focused on large 2026 AI capex; broker logs for the six specified banks did not surface clearly dated, target‑bearing entries during the session. We can extend the scrape on request. (marketbeat.com)
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Morgan Stanley | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| JP Morgan | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Bank of America | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Citigroup | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Wells Fargo | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
TSLA - Tesla Inc.
MarketBeat shows ongoing coverage by all six banks; a recent Citi entry lowered target to $258 with Neutral; other bank entries on the public page did not display clear, dated targets in our single‑pass scrape. (marketbeat.com)
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Morgan Stanley | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| JP Morgan | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Bank of America | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Citigroup | Neutral | $258 | - | Lowered from $274 (date not shown inline). | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Wells Fargo | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
AVGO - Broadcom Inc.
Broker list confirms coverage by all six banks; specific, dated target moves for the six were not exposed in the immediate page view used here. Can pull full logs on request. (marketbeat.com)
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| Morgan Stanley | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| JP Morgan | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| Bank of America | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| Citigroup | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| Wells Fargo | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
TSM - Taiwan Semiconductor Manufacturing Co. Ltd.
Could not retrieve clearly dated target entries for the six specified banks from the MarketBeat public page on a single pass. We can expand the crawl (e.g., The Fly/TipRanks logs) if you want TSM covered in depth. (marketbeat.com)
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| Morgan Stanley | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| JP Morgan | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| Bank of America | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| Citigroup | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| Wells Fargo | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
Highlights
- AAPL: MS $315 OW (Mar 23) and BofA $320 Buy (Mar 23) — consensus ~$315, Buy. (marketbeat.com)
- MSFT: GS $600 Buy (Jan 29) and MS $650 OW (Jan 14) vs JPM $550 OW — consensus ≈$595, Buy. (capital.com)
- GOOGL: JPM $395 OW (Feb 5) and GS $375 Buy (Jan 13) — consensus ≈$369, Buy. (marketbeat.com)
- NVDA: BofA $300 Buy (Feb 25) and JPM $265 OW (Feb 26) — consensus ≈$275, Buy. (marketbeat.com)
- AMZN: GS/MS at $300 (Jan/Feb) with WFC $304 OW; Citi at $250 (Mar 17) — consensus ≈$288, Buy. (marketbeat.com)
Notes and limitations: Where MarketBeat’s latest broker log did not show a target on the visible entry (e.g., AAPL: GS; AMZN: JPM), target_price is set to null and the rating/date are still recorded from the same source. If you want, I can run a deeper pass (The Fly/TipRanks/press PDFs) specifically for META, TSLA, AVGO and TSM to populate all six banks with targets and exact timestamps across the last 3–6 months.
IPO Calendar
Timeframe: Next 30 days: March 24, 2026 – April 24, 2026
The near-term U.S. IPO slate is thin and skewed to Nasdaq. Renaissance Capital’s public calendar shows no NYSE IPOs scheduled, while Nasdaq lists a small set of biotech/industrial/royalty names and one direct listing. Broader commentary notes the calendar remains light even after a pickup in 2025, though Nasdaq has argued market drivers are becoming more supportive into 2026. (renaissancecapital.com)
Salspera, Inc. (TKVA)
- Expected listing date: Late March 2026 (pricing day TBD)
- Price range: $14.00 – $16.00 per share
- Shares offered: 5,666,666 primary shares (+850,000 overallotment option)
- Exchange: Nasdaq
- Lead underwriters: Kingswood Capital Partners, LLC (sole bookrunner)
- Business summary: Clinical‑stage biotech developing “live biotherapeutic” bacterial immunotherapies for solid tumors. Lead candidate Saltikva (engineered Salmonella‑IL2) is being advanced toward a Phase 3 program in metastatic pancreatic cancer; proceeds are earmarked primarily for that Phase 3 trial and Phase 2 programs in osteosarcoma and colorectal cancer. (sec.gov)
- Notes: Terms and size come from the preliminary prospectus and free writing prospectus; exact pricing/listing date not posted as of March 24, 2026. Renaissance calendar also shows the deal on the week’s slate. (sec.gov)
- Sources: SEC S‑1/A (filed March 10, 2026), SEC Free Writing Prospectus (March 2026), FierceBiotech coverage (March 11, 2026), Renaissance Capital – Upcoming IPO Calendar
The Metals Royalty Company Inc. (TMCR)
- Expected listing date: Targeting by March 31, 2026 (direct listing; timing subject to SEC effectiveness/Nasdaq approval)
- Shares offered: No primary shares; direct listing of existing shares
- Exchange: Nasdaq Capital Market
- Business summary: Royalty/streaming platform focused on critical minerals for U.S. supply‑chain security. Portfolio anchored by a 2.0% gross overriding royalty on the NORI polymetallic nodule project operated by TMC the metals company; plans to list via a Nasdaq direct listing (no underwriters). Stifel is engaged as financial advisor for the listing process. (sec.gov)
- Notes: This is a direct listing (not a traditional IPO). The company’s F‑1 states escrowed proceeds tied to listing approval must be released by March 31, 2026; otherwise funds are returned. Nasdaq and third‑party notices reference the planned listing and investor webinar; no definitive first trade date was posted as of March 24, 2026. (sec.gov)
- Sources: SEC F‑1 (filed late Feb/early Mar 2026), Nasdaq newsroom notice (Mar 10–16, 2026), Renaissance Capital profile (direct listing)
HMH Holding Inc. (HMH)
- Expected listing date: April 2026 (TBD)
- Price range: $19.00 – $22.00 per share (per Renaissance calendar)
- Shares offered: 10.5 million shares (per Renaissance calendar)
- Exchange: Nasdaq Global Select Market
- Lead underwriters: J.P. Morgan Securities LLC, Piper Sandler & Co., Evercore Group L.L.C., Citigroup Global Markets Inc., DNB Carnegie, Inc., Nordea Bank Abp, Stifel, Nicolaus & Company, Incorporated
- Business summary: Provider of highly engineered drilling equipment, systems, and aftermarket services for offshore and onshore oil & gas operations. Formed in 2021 via combination of Baker Hughes’ Subsea/Surface Drilling Systems and Akastor’s MHWirth; proceeds are expected to fund a reorganization including purchase of interests from Baker Hughes/Akastor and general corporate purposes. (sec.gov)
- Notes: Underwriters and intended Nasdaq listing are from the latest S‑1/A. Share count and price range are shown on Renaissance Capital’s live calendar; the corresponding SEC filing still used placeholder terms at last update, so these may change. No firm pricing date as of March 24, 2026. (sec.gov)
- Sources: SEC S‑1/A (2026) – Listing/Underwriters, Renaissance Capital – Upcoming IPO Calendar, Akastor/Baker Hughes background releases (formation history)
This calendar reflects filings and reputable IPO calendars available as of March 24, 2026. Direct listings (e.g., TMCR) are included given they result in new U.S. exchange listings but do not involve primary share issuance. All terms/dates remain subject to SEC effectiveness, exchange approval, and market conditions; issuers may adjust ranges, share counts, timing, or withdraw offerings.
Sources
- Stock Ratings: https://capital.com/en-int/market-updates/microsoft-stock-forecast-27-02-2026, https://www.investing.com/news/analyst-ratings/morgan-stanley-reiterates-overweight-rating-on-microsoft-stock-at-650-93CH-4446158, https://www.marketbeat.com/instant-alerts/alphabet-nasdaqgoogl-given-new-39500-price-target-at-jpmorgan-chase-co-2026-02-05/, https://www.marketbeat.com/instant-alerts/alphabet-nasdaqgoogl-given-new-39500-price-target-at-jpmorgan-chase-co-2026-02-05/?utm_source=openai, https://www.marketbeat.com/instant-alerts/citigroup-increases-nvidia-nasdaqnvda-price-target-to-30000-2026-02-26/, https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/, https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/, https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/, https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/, https://www.marketbeat.com/stocks/NASDAQ/META/forecast/, https://www.marketbeat.com/stocks/NASDAQ/META/forecast/?utm_source=openai, https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/, https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/, https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/, https://www.marketbeat.com/stocks/NYSE/TSM/forecast/
- IPO Calendar: https://www.renaissancecapital.com/IPO-Center/Calendar, https://www.sec.gov/Archives/edgar/data/0002021880/000119312526029572/d75409ds1a.htm, https://www.sec.gov/Archives/edgar/data/0002087398/000110465926021062/tm2526563-10_f1.htm, https://www.sec.gov/Archives/edgar/data/2084032/000121390026025748/ea0256863-08.htm
Disclaimer
This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.
Generated on: 2026-03-24 at 11:46 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.
Powered by Alpha Signal Monitor | Market Intelligence Through AI